Taken together, our data provide further evidence that EIF4EBP1 is a transcriptional target of MYCN, potentially providing a mechanistic basis for the observed overexpression of EIF4EBP1 in MYCN-amplified NB patients. This evidence concerns the gene EIF4EBP1 and neuroblastoma.